雅各臣科研(02633.HK)获Smartfish大中华区独家分销权
雅各臣科研制药(02633.HK)公布,与挪威保健营养公司Smartfish AS签署独家分销协议,於大中华及亚洲推出Smartfish保健营养系列产品,包括「Smartfish Recharge」运动营养产品、「Smartfish Resolve」改善新陈代谢健康及糖尿病护理产品、「Smartfish Reflect」改善成人脑部健康及认知功能产品及Z「Smartfish乳浆」有助儿童脑部发育产品,为期十年。
此外,双方同意公司为优先合作夥伴以扩展泰国、越南、柬埔寨、新加坡及其他亚洲国家的市场。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.